3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
27
Burkitt Lymphoma
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasm Metastasis
4
Leukemia, Biphenotypic, Acute
4
Immunoglobulin Light-chain Amyloidosis
4
Smoldering Multiple Myeloma
3
Down Syndrome
3
Carcinoma, Non-Small-Cell Lung
3
Recurrence
2
Neoplasms
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Lung Neoplasms
2
Hodgkin Disease
2
Breast Neoplasms
2
Brain Neoplasms
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Plasmacytoma
1
Myelodysplastic Syndromes
1
Meningioma
1
Mastocytosis, Systemic
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Plasma Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Interventions
Specimen Handling
7
Biopsy
6
Cyclophosphamide
5
ruxolitinib
4
Mycophenolic Acid
4
Busulfan
4
fludarabine phosphate
3
fludarabine
3
Whole-Body Irradiation
3
Tacrolimus
3
Melphalan
3
Injections
3
Decitabine
3
Cyclosporine
3
Azacitidine
3
venetoclax
2
decitabine and cedazuridine drug combination
2
Sirolimus
2
Methotrexate
2
Granulocyte Colony-Stimulating Factor
2
veliparib
1
tocilizumab
1
tagraxofusp
1
posaconazole
1
peginterferon alfa-2b
1
onvansertib
1
merphos
1
iadademstat
1
gilteritinib
1
fedratinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic-Myeloproliferative Diseases
×
dexamethasone 21-phosphate
×
1 year
×
Clear all
No trials found.